Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C H Jurgensen

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Agents and Actions|June 1, 1989
Inhibition of neutrophil adherence to endothelial cells by 3-deazaadenosineC H Jurgensen, G Wolberg, T P Zimmerman
Journal of Immunology (Baltimore, Md. : 1950)|June 15, 1986
Production of B cell growth factor by normal human B cellsC H Jurgensen, J L Ambrus, A S Fauci
Clinical and Experimental Immunology|July 1, 1984
Modulation of human B cell responses by a monoclonal antibody to an activation antigen 4F2T L Gerrard, C H Jurgensen, A S Fauci
Cellular Immunology|December 1, 1983
Differential effect of monoclonal anti-DR antibody on monocytes in antigen- and mitogen-stimulated responses: mechanism of inhibition and relationship to interleukin 1 secretionT L Gerrard, C H Jurgensen, A S Fauci
Journal of Immunology (Baltimore, Md. : 1950)|January 15, 1990
3-deazaadenosine inhibits leukocyte adhesion and ICAM-1 biosynthesis in tumor necrosis factor-stimulated human endothelial cellsC H Jurgensen, B E Huber, T P Zimmerman, et al.
Cellular Immunology|October 1, 1985
Activated human T cells can present alloantigens but cannot present soluble antigensT L Gerrard, D J Volkman, C H Jurgensen, et al.
Cellular Immunology|April 1, 1984
Increased expression of HLA-DR antigens in hydrocortisone-treated monocytesT L Gerrard, T R Cupps, C H Jurgensen, et al.
The Journal of Experimental Medicine|October 1, 1985
Purification to homogeneity of a high molecular weight human B cell growth factor; demonstration of specific binding to activated B cells; and development of a monoclonal antibody to the factorJ L Ambrus, C H Jurgensen, E J Brown, et al.
Human Immunology|December 1, 1986
Activated human T cells can present denatured antigenT L Gerrard, D J Volkman, C H Jurgensen, et al.
Cellular Immunology|May 1, 1984
Hydrocortisone-mediated inhibition of monocyte antigen presentation: dissociation of inhibitory effect and expression of DR antigensT L Gerrard, T R Cupps, C H Jurgensen, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Agents and Actions|June 1, 1989
Inhibition of neutrophil adherence to endothelial cells by 3-deazaadenosineC H Jurgensen, G Wolberg, T P Zimmerman
Journal of Immunology (Baltimore, Md. : 1950)|June 15, 1986
Production of B cell growth factor by normal human B cellsC H Jurgensen, J L Ambrus, A S Fauci
Clinical and Experimental Immunology|July 1, 1984
Modulation of human B cell responses by a monoclonal antibody to an activation antigen 4F2T L Gerrard, C H Jurgensen, A S Fauci
Cellular Immunology|December 1, 1983
Differential effect of monoclonal anti-DR antibody on monocytes in antigen- and mitogen-stimulated responses: mechanism of inhibition and relationship to interleukin 1 secretionT L Gerrard, C H Jurgensen, A S Fauci
Journal of Immunology (Baltimore, Md. : 1950)|January 15, 1990
3-deazaadenosine inhibits leukocyte adhesion and ICAM-1 biosynthesis in tumor necrosis factor-stimulated human endothelial cellsC H Jurgensen, B E Huber, T P Zimmerman, et al.
Cellular Immunology|October 1, 1985
Activated human T cells can present alloantigens but cannot present soluble antigensT L Gerrard, D J Volkman, C H Jurgensen, et al.
Cellular Immunology|April 1, 1984
Increased expression of HLA-DR antigens in hydrocortisone-treated monocytesT L Gerrard, T R Cupps, C H Jurgensen, et al.
The Journal of Experimental Medicine|October 1, 1985
Purification to homogeneity of a high molecular weight human B cell growth factor; demonstration of specific binding to activated B cells; and development of a monoclonal antibody to the factorJ L Ambrus, C H Jurgensen, E J Brown, et al.
Human Immunology|December 1, 1986
Activated human T cells can present denatured antigenT L Gerrard, D J Volkman, C H Jurgensen, et al.
Cellular Immunology|May 1, 1984
Hydrocortisone-mediated inhibition of monocyte antigen presentation: dissociation of inhibitory effect and expression of DR antigensT L Gerrard, T R Cupps, C H Jurgensen, et al.
Pageof 2